COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study

In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Krieger, Israel, Erez, Galit, Weinstein, Orly, Cohen, Arnon Dov, Tzur Bitan, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265716/
https://www.ncbi.nlm.nih.gov/pubmed/34240292
http://dx.doi.org/10.1007/s10803-021-05187-2
_version_ 1783719794352062464
author Krieger, Israel
Erez, Galit
Weinstein, Orly
Cohen, Arnon Dov
Tzur Bitan, Dana
author_facet Krieger, Israel
Erez, Galit
Weinstein, Orly
Cohen, Arnon Dov
Tzur Bitan, Dana
author_sort Krieger, Israel
collection PubMed
description In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p < .001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.
format Online
Article
Text
id pubmed-8265716
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82657162021-07-09 COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study Krieger, Israel Erez, Galit Weinstein, Orly Cohen, Arnon Dov Tzur Bitan, Dana J Autism Dev Disord Original Paper In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p < .001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks. Springer US 2021-07-08 2023 /pmc/articles/PMC8265716/ /pubmed/34240292 http://dx.doi.org/10.1007/s10803-021-05187-2 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Krieger, Israel
Erez, Galit
Weinstein, Orly
Cohen, Arnon Dov
Tzur Bitan, Dana
COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title_full COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title_fullStr COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title_full_unstemmed COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title_short COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
title_sort covid-19 morbidity among individuals with autistic spectrum disorder: a matched controlled population-based study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265716/
https://www.ncbi.nlm.nih.gov/pubmed/34240292
http://dx.doi.org/10.1007/s10803-021-05187-2
work_keys_str_mv AT kriegerisrael covid19morbidityamongindividualswithautisticspectrumdisorderamatchedcontrolledpopulationbasedstudy
AT erezgalit covid19morbidityamongindividualswithautisticspectrumdisorderamatchedcontrolledpopulationbasedstudy
AT weinsteinorly covid19morbidityamongindividualswithautisticspectrumdisorderamatchedcontrolledpopulationbasedstudy
AT cohenarnondov covid19morbidityamongindividualswithautisticspectrumdisorderamatchedcontrolledpopulationbasedstudy
AT tzurbitandana covid19morbidityamongindividualswithautisticspectrumdisorderamatchedcontrolledpopulationbasedstudy

Ejemplares similares